Literature DB >> 26354823

Laboratory Diagnosis of Pertussis.

Anneke van der Zee1, Joop F P Schellekens2, Frits R Mooi3.   

Abstract

The introduction of vaccination in the 1950s significantly reduced the morbidity and mortality of pertussis. However, since the 1990s, a resurgence of pertussis has been observed in vaccinated populations, and a number of causes have been proposed for this phenomenon, including improved diagnostics, increased awareness, waning immunity, and pathogen adaptation. The resurgence of pertussis highlights the importance of standardized, sensitive, and specific laboratory diagnoses, the lack of which is responsible for the large differences in pertussis notifications between countries. Accurate laboratory diagnosis is also important for distinguishing between the several etiologic agents of pertussis-like diseases, which involve both viruses and bacteria. If pertussis is diagnosed in a timely manner, antibiotic treatment of the patient can mitigate the symptoms and prevent transmission. During an outbreak, timely diagnosis of pertussis allows prophylactic treatment of infants too young to be (fully) vaccinated, for whom pertussis is a severe, sometimes fatal disease. Finally, reliable diagnosis of pertussis is required to reveal trends in the (age-specific) disease incidence, which may point to changes in vaccine efficacy, waning immunity, and the emergence of vaccine-adapted strains. Here we review current approaches to the diagnosis of pertussis and discuss their limitations and strengths. In particular, we emphasize that the optimal diagnostic procedure depends on the stage of the disease, the age of the patient, and the vaccination status of the patient.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26354823      PMCID: PMC4575397          DOI: 10.1128/CMR.00031-15

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  259 in total

Review 1.  Towards improved accuracy of Bordetella pertussis nucleic acid amplification tests.

Authors:  Michael Loeffelholz
Journal:  J Clin Microbiol       Date:  2012-03-21       Impact factor: 5.948

2.  Use of Bordetella pertussis BP3385 to establish a cutoff value for an IS481-targeted real-time PCR assay.

Authors:  J L Guthrie; C Seah; S Brown; P Tang; F Jamieson; S J Drews
Journal:  J Clin Microbiol       Date:  2008-09-10       Impact factor: 5.948

3.  Isotype and antigen specificity of pertussis agglutinins following whole-cell pertussis vaccination and infection with Bordetella pertussis.

Authors:  C M Mink; C H O'Brien; S Wassilak; A Deforest; B D Meade
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

4.  Polymerase chain reaction assay for pertussis: simultaneous detection and discrimination of Bordetella pertussis and Bordetella parapertussis.

Authors:  A van der Zee; C Agterberg; M Peeters; J Schellekens; F R Mooi
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

5.  Molecular evolution and host adaptation of Bordetella spp.: phylogenetic analysis using multilocus enzyme electrophoresis and typing with three insertion sequences.

Authors:  A van der Zee; F Mooi; J Van Embden; J Musser
Journal:  J Bacteriol       Date:  1997-11       Impact factor: 3.490

6.  Development of a real-time PCR for the identification of Bordetella pertussis and Bordetella parapertussis.

Authors:  A Ménard; P Lehours; J Sarlangue; C Bébéar; F Mégraud; B de Barbeyrac
Journal:  Clin Microbiol Infect       Date:  2007-04       Impact factor: 8.067

7.  Development and evaluation of dual-target real-time polymerase chain reaction assays to detect Bordetella spp.

Authors:  Kathleen M Tatti; Kai-Hui Wu; Maria Lucia Tondella; Pamela K Cassiday; Margaret M Cortese; Patricia P Wilkins; Gary N Sanden
Journal:  Diagn Microbiol Infect Dis       Date:  2008-04-25       Impact factor: 2.803

8.  Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study.

Authors:  Dorothy Xing; Carl Heinz Wirsing von König; Penny Newland; Marion Riffelmann; Bruce D Meade; Michael Corbel; Rose Gaines-Das
Journal:  Clin Vaccine Immunol       Date:  2008-12-24

9.  The rationale and method for constructing internal control DNA used in pertussis polymerase chain reaction.

Authors:  F M Müller; N Schnitzler; O Cloot; P Kockelkorn; G Haase; Z Li
Journal:  Diagn Microbiol Infect Dis       Date:  1998-08       Impact factor: 2.803

10.  Bordetella pertussis strains with increased toxin production associated with pertussis resurgence.

Authors:  Frits R Mooi; Inge H M van Loo; Marjolein van Gent; Qiushui He; Marieke J Bart; Kees J Heuvelman; Sabine C de Greeff; Dimitri Diavatopoulos; Peter Teunis; Nico Nagelkerke; Jussi Mertsola
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

View more
  37 in total

Review 1.  Prevention of pertussis: An unresolved problem.

Authors:  Susanna Esposito; Nicola Principi
Journal:  Hum Vaccin Immunother       Date:  2018-07-24       Impact factor: 3.452

2.  Abundance of the nasopharyngeal microbiome effects pertussis diagnosis and explains the sensitivity difference between bacterial culture and real-time PCR.

Authors:  Yijun Ding; Qing Wang; Dongfang Li; Kaihu Yao; Tianyou Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-03       Impact factor: 3.267

3.  Laboratory Performance and Clinical Correlation of Real-time Polymerase Chain Reaction as a Diagnostic Test for Bordetella Pertussis Isolated from Patients in Oman.

Authors:  Hala Al-Hinai; Azza Al-Rashdi; Saleh Al Azri
Journal:  Oman Med J       Date:  2022-05-31

4.  Descriptive Overview of Pertussis Epidemiology Among Older Adults in Europe During 2010-2020.

Authors:  Enas Bahar; Daria Shamarina; Yan Sergerie; Piyali Mukherjee
Journal:  Infect Dis Ther       Date:  2022-07-06

Review 5.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

6.  Identification of etiologic agents and clinical characteristics for patients suspected of having pertussis in a large Children's Hospital in China.

Authors:  Yue Tao; Mingyu Tang; Lijuan Luo; Long Xiang; Yijun Xia; Biru Li; Qing Cao; Xi Mo
Journal:  Ann Transl Med       Date:  2019-09

7.  Evaluation of Commercial Assays for Single-Point Diagnosis of Pertussis in the US.

Authors:  Lucia C Pawloski; Brian D Plikaytis; Monte D Martin; Stacey W Martin; Harry E Prince; Mary Lapé-Nixon; M Lucia Tondella
Journal:  J Pediatric Infect Dis Soc       Date:  2017-09-01       Impact factor: 3.164

8.  Is it time to administer acellular pertussis vaccine to childbearing age/pregnant women in all areas using whole-cell pertussis vaccination schedule?

Authors:  Abdoulreza Esteghamati; Shirin Sayyahfar; Yousef Alimohamadi; Sarvenaz Salahi; Mahmood Faramarzi
Journal:  Ther Adv Vaccines Immunother       Date:  2021-05-25

9.  Burden of whooping cough in China (PertussisChina): study protocol of a prospective, population-based case-control study.

Authors:  Jianxing Yu; Hanqing He; Yanyang Zhang; Yuan Gao; Chuanwei Chen; Juan Xu; Li Xu; Xiaoxiao Zhang; Qianqian Zhou; Yao Zhu; Xuewen Tang; Yonghao Guo; Zhiping Chen; Zhujun Shao
Journal:  BMJ Open       Date:  2022-03-10       Impact factor: 2.692

Review 10.  Rediscovering Pertussis.

Authors:  Manuela Zlamy
Journal:  Front Pediatr       Date:  2016-06-08       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.